8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Feb 2, 2016)

Filed February 2, 2016For Securities:EW

Summary

This 8-K filing from Edwards Lifesciences (EW) on February 2, 2016, primarily serves to furnish their press release detailing fourth-quarter 2015 financial results. While the filing itself doesn't contain the detailed numbers, it officially makes the press release, dated February 2, 2016, available as an exhibit. Investors should refer to this attached press release (Exhibit 99.1) for the specific financial performance, operational highlights, and any forward-looking statements made by the company for the period ending December 31, 2015. Crucially, this filing is furnished and not "filed" under the Securities Exchange Act of 1934. This means the information contained within the press release, while publicly disclosed, is not subject to the same level of regulatory scrutiny as if it were formally filed. Investors should be aware of this distinction when assessing the reported information, focusing on the content of the press release itself for actionable insights into the company's performance and future outlook.

Key Highlights

  • 1Edwards Lifesciences filed an 8-K on February 2, 2016, reporting on its fourth-quarter 2015 financial results.
  • 2The primary purpose of the filing is to furnish a press release containing the financial results.
  • 3The press release is dated February 2, 2016, and is incorporated by reference as Exhibit 99.1.
  • 4Investors need to consult Exhibit 99.1 for the detailed financial performance of Edwards Lifesciences for Q4 2015.
  • 5The filing explicitly states that the information furnished is not deemed 'filed' for the purposes of the Securities Exchange Act of 1934.
  • 6This implies that the disclosed information is for informational purposes and not subject to the full liability provisions of a formal filing.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially release and incorporate by reference Edwards Lifesciences' press release detailing their financial results for the fourth quarter of 2015.

The detailed financial results for Q4 2015 are contained within the press release furnished as Exhibit 99.1 to this 8-K filing. You should refer to that document for specific numbers, revenue, earnings, and other performance metrics.

No, the filing explicitly states that the information furnished under Item 2.02, including the press release, shall not be deemed to be 'filed' for purposes of the Securities Exchange Act of 1934. This means it's an informational disclosure, not a formal filing subject to the same liabilities.

The event date mentioned is February 1, 2016, which likely corresponds to the date the company's board or management reviewed and approved the financial results being announced, prior to the press release issuance on February 2, 2016.